You are here

Article info

Article menu
Download PDFPDF
Correspondence
Hydroxychloroquine reduces the risk of covid-19 in patients with rheumatic diseases: myth or reality?

Authors

  1. Correspondence to Professor Zhuoli Zhang, Department of Rheumatology and Clinical Immunology, Peking University First Hospital, Beijing, China; zhuoli.zhang{at}126.com
View Full Text

Citation

Xie W, Wang Y, Zhang Z
Hydroxychloroquine reduces the risk of covid-19 in patients with rheumatic diseases: myth or reality?
Annals of the Rheumatic Diseases 2021;80:e6.

Publication history

  • Received April 9, 2020
  • Accepted April 13, 2020
  • First published April 21, 2020.
Online issue publication 
December 14, 2020

Article Versions

Copyright information

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage